Search

Search Constraints

You searched for: Author/Creator Venkitaraman, Ramachandran

Search Results

2. Effect of the COVID-19 pandemic on cancer treatment and research. Issue 6 (June 2020)

3. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial. Issue 3 (March 2020)

4. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial. Issue 7 (July 2022)

5. Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST). Issue 22 (1st August 2022)